Nataly Tarasenko

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity

Ada Rephaeli, S Waks-Yona, Abraham Nudelman et al. · British Journal of Cancer · 2007 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties

Diana Blank‐Porat, Tal Gruss-Fischer, Nataly Tarasenko et al. · Cancer Letters · 2007 · 40 citations

Pharmacy, Medicinal Chemistry, Oncology +11

The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity

Nataly Tarasenko, Gania Kessler‐Icekson, P. Boer et al. · Investigational New Drugs · 2010 · 39 citations

Medicine, Oncology, Pharmacology +14

<i>In vivo</i> and <i>in vitro</i> antitumor activity of butyroyloxymethyl‐diethyl phosphate (AN‐7), a histone deacetylase inhibitor, in human prostate cancer

Ada Rephaeli, Diana Blank‐Porat, Nataly Tarasenko et al. · International Journal of Cancer · 2005 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)

Nataly Tarasenko, Abraham Nudelman, Igor Tarasenko et al. · Clinical & Experimental Metastasis · 2008 · 38 citations

Medicine, Oncology, Pharmacology +12